BIOCON.NS Profit & Loss

Biocon Ltd.

Profit & Loss · 8 years on file (FY2018-19 to FY2025-26) · fetched 2026-08-23 21:39

Line item	FY2018-19	FY2019-20	FY2020-21	FY2021-22	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹55.14 Bn	₹63.67 Bn	₹71.06 Bn	₹81.84 Bn	₹111.74 Bn	₹147.56 Bn	₹152.62 Bn	₹169.27 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	₹60.29 Bn	₹63.67 Bn	₹71.06 Bn	₹81.84 Bn	₹111.74 Bn	₹147.56 Bn	₹152.62 Bn	₹169.27 Bn	SegmentRevenueFromOperations
Other Income	₹1.44 Bn	₹1.61 Bn	₹2.54 Bn	₹2.13 Bn	₹3.76 Bn	₹8.65 Bn	₹12.08 Bn	₹3.42 Bn	OtherIncome
Total Income	₹56.59 Bn	₹65.29 Bn	₹73.60 Bn	₹83.97 Bn	₹115.50 Bn	₹156.21 Bn	₹164.70 Bn	₹172.69 Bn	Income
Cost of Materials Consumed	₹19.80 Bn	₹21.68 Bn	₹24.30 Bn	₹28.14 Bn	₹31.91 Bn	₹50.72 Bn	₹42.77 Bn	₹52.78 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹1.27 Bn	₹0.85 Bn	₹0.68 Bn	₹1.61 Bn	₹6.26 Bn	₹6.83 Bn	₹6.27 Bn	₹13.63 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹-2.10 Bn	₹-2.01 Bn	₹-2.90 Bn	₹-2.57 Bn	₹-1.54 Bn	₹-8.57 Bn	₹2.94 Bn	₹-9.49 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹11.65 Bn	₹14.59 Bn	₹17.41 Bn	₹18.80 Bn	₹21.81 Bn	₹26.64 Bn	₹31.44 Bn	₹35.08 Bn	EmployeeBenefitExpense
Finance Costs	₹0.71 Bn	₹0.65 Bn	₹0.58 Bn	₹0.68 Bn	₹4.19 Bn	₹9.74 Bn	₹8.97 Bn	₹9.90 Bn	FinanceCosts
Depreciation and Amortisation	₹4.48 Bn	₹5.52 Bn	₹7.15 Bn	₹8.14 Bn	₹11.13 Bn	₹15.69 Bn	₹16.87 Bn	₹19.57 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹10.59 Bn	₹12.53 Bn	₹15.04 Bn	₹16.15 Bn	₹28.18 Bn	₹38.95 Bn	₹37.53 Bn	₹42.73 Bn	OtherExpenses
Total Expenses	₹46.39 Bn	₹53.81 Bn	₹62.26 Bn	₹70.96 Bn	₹101.95 Bn	₹140.00 Bn	₹146.80 Bn	₹164.19 Bn	Expenses
Profit Before Exceptional Items and Tax	₹10.19 Bn	₹11.47 Bn	₹11.34 Bn	₹13.01 Bn	₹13.55 Bn	₹16.21 Bn	₹17.90 Bn	₹8.51 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹1.95 Bn	₹0.68 Bn	₹0.13 Bn	₹-1.11 Bn	₹-2.91 Bn	₹-0.12 Bn	₹0.96 Bn	₹-4.03 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹12.14 Bn	₹12.15 Bn	₹11.47 Bn	₹11.90 Bn	₹10.64 Bn	₹16.09 Bn	₹18.87 Bn	₹4.48 Bn	ProfitBeforeTax
Tax Expense	₹2.12 Bn	₹3.15 Bn	₹2.21 Bn	₹2.12 Bn	₹2.54 Bn	₹2.27 Bn	₹4.57 Bn	₹0.79 Bn	TaxExpense
Net Profit (incl. minority interest)	₹10.03 Bn	₹8.71 Bn	₹8.46 Bn	₹7.72 Bn	₹6.43 Bn	₹12.98 Bn	₹14.29 Bn	₹3.69 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	₹9.05 Bn	₹7.48 Bn	₹7.41 Bn	₹6.48 Bn	₹4.63 Bn	₹10.22 Bn	₹10.13 Bn	₹3.86 Bn	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹15.30	₹6.32	₹6.24	₹5.44	₹3.88	₹8.55	₹8.46	₹2.82	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹15.20	₹6.30	₹6.19	₹5.42	₹3.87	₹8.54	₹8.46	₹2.82	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from BIOCON.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).